comparemela.com

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Friday. JAZZ has been the subject of a number of other reports. Stifel Nicolaus upped their price target on shares of Jazz Pharmaceuticals from $225.00 to […]

Related Keywords

Canada ,United States ,Patricia Carr ,Neenam Patil ,Stifel Nicolaus ,Jazz Pharmaceuticals Company Profile ,Jazz Pharmaceuticals Trading Down ,News Ratings For Jazz Pharmaceuticals Daily ,Covestor Ltd ,Barclays ,Royal Bank ,Cantor Fitzgerald ,Jazz Pharmaceuticals ,Institutional Investors Weigh In On Jazz Pharmaceuticals ,Insider Transactions At Jazz Pharmaceuticals ,Rise Advisors ,Analyst Recommendations For Jazz Pharmaceuticals ,Cape Investment Advisory Inc ,Get Free Report ,Pharmaceuticals Trading Down ,Investment Advisory ,Wealth Management ,Jazz Pharmaceuticals Daily ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.